Overview
- The Paris criminal court postponed proceedings to June in the case against Henri Joyeux and Jean‑Bernard Fourtillan over alleged unauthorized trials on patients with Parkinson’s and Alzheimer’s.
- Prosecutors say at least 380 people received patches combining valentonine and 6‑methoxy‑harmalan at a Catholic abbey near Poitiers in 2018–2019, financed through patient donations via the Fonds Josefa.
- France’s medicines regulator, the ANSM, halted the activities in September 2019 after a report and has joined the case as a civil party alongside the medical and pharmacy orders.
- Only four former participants have filed as civil parties despite the several hundred involved in the experiments.
- Experts have warned that some participants were told to stop standard treatments, a change described as potentially serious or even fatal for Parkinson’s patients.